These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24824780)

  • 1. MCC inhibits beta-catenin transcriptional activity by sequestering DBC1 in the cytoplasm.
    Pangon L; Mladenova D; Watkins L; Van Kralingen C; Currey N; Al-Sohaily S; Lecine P; Borg JP; Kohonen-Corish MR
    Int J Cancer; 2015 Jan; 136(1):55-64. PubMed ID: 24824780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive regulation of β-catenin-PROX1 signaling axis by DBC1 in colon cancer progression.
    Yu EJ; Kim SH; Kim HJ; Heo K; Ou CY; Stallcup MR; Kim JH
    Oncogene; 2016 Jun; 35(26):3410-8. PubMed ID: 26477307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DBC1 regulates Wnt/β-catenin-mediated expression of MACC1, a key regulator of cancer progression, in colon cancer.
    Kim HJ; Moon SJ; Kim SH; Heo K; Kim JH
    Cell Death Dis; 2018 Aug; 9(8):831. PubMed ID: 30082743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutated in colorectal cancer, a putative tumor suppressor for serrated colorectal cancer, selectively represses beta-catenin-dependent transcription.
    Fukuyama R; Niculaita R; Ng KP; Obusez E; Sanchez J; Kalady M; Aung PP; Casey G; Sizemore N
    Oncogene; 2008 Oct; 27(46):6044-55. PubMed ID: 18591935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. hMOF acetylation of DBC1/CCAR2 prevents binding and inhibition of SirT1.
    Zheng H; Yang L; Peng L; Izumi V; Koomen J; Seto E; Chen J
    Mol Cell Biol; 2013 Dec; 33(24):4960-70. PubMed ID: 24126058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of DBC1 as a transcriptional repressor for BRCA1.
    Hiraike H; Wada-Hiraike O; Nakagawa S; Koyama S; Miyamoto Y; Sone K; Tanikawa M; Tsuruga T; Nagasaka K; Matsumoto Y; Oda K; Shoji K; Fukuhara H; Saji S; Nakagawa K; Kato S; Yano T; Taketani Y
    Br J Cancer; 2010 Mar; 102(6):1061-7. PubMed ID: 20160719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DBC1 phosphorylation by ATM/ATR inhibits SIRT1 deacetylase in response to DNA damage.
    Zannini L; Buscemi G; Kim JE; Fontanella E; Delia D
    J Mol Cell Biol; 2012 Oct; 4(5):294-303. PubMed ID: 22735644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repression of estrogen receptor beta function by putative tumor suppressor DBC1.
    Koyama S; Wada-Hiraike O; Nakagawa S; Tanikawa M; Hiraike H; Miyamoto Y; Sone K; Oda K; Fukuhara H; Nakagawa K; Kato S; Yano T; Taketani Y
    Biochem Biophys Res Commun; 2010 Feb; 392(3):357-62. PubMed ID: 20074560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carboxamide SIRT1 inhibitors block DBC1 binding via an acetylation-independent mechanism.
    Hubbard BP; Loh C; Gomes AP; Li J; Lu Q; Doyle TL; Disch JS; Armour SM; Ellis JL; Vlasuk GP; Sinclair DA
    Cell Cycle; 2013 Jul; 12(14):2233-40. PubMed ID: 23892437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-catenin inhibits promyelocytic leukemia protein tumor suppressor function in colorectal cancer cells.
    Satow R; Shitashige M; Jigami T; Fukami K; Honda K; Kitabayashi I; Yamada T
    Gastroenterology; 2012 Mar; 142(3):572-81. PubMed ID: 22155184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative regulation of the deacetylase SIRT1 by DBC1.
    Zhao W; Kruse JP; Tang Y; Jung SY; Qin J; Gu W
    Nature; 2008 Jan; 451(7178):587-90. PubMed ID: 18235502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent inactivation of MCC/CTNNBIP1 and overexpression of phospho-beta-catenin(Y654) are associated with breast carcinoma: Clinical and prognostic significance.
    Mukherjee N; Dasgupta H; Bhattacharya R; Pal D; Roy R; Islam S; Alam N; Biswas J; Roy A; Roychoudhury S; Panda CK
    Biochim Biophys Acta; 2016 Sep; 1862(9):1472-84. PubMed ID: 27208794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
    Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
    Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A positive role of DBC1 in PEA3-mediated progression of estrogen receptor-negative breast cancer.
    Kim HJ; Kim SH; Yu EJ; Seo WY; Kim JH
    Oncogene; 2015 Aug; 34(34):4500-8. PubMed ID: 25417701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SIRT7 promotes thyroid tumorigenesis through phosphorylation and activation of Akt and p70S6K1 via DBC1/SIRT1 axis.
    Li H; Tian Z; Qu Y; Yang Q; Guan H; Shi B; Ji M; Hou P
    Oncogene; 2019 Jan; 38(3):345-359. PubMed ID: 30093629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenomatous polyposis coli (APC) membrane recruitment 3, a member of the APC membrane recruitment family of APC-binding proteins, is a positive regulator of Wnt-β-catenin signalling.
    Brauburger K; Akyildiz S; Ruppert JG; Graeb M; Bernkopf DB; Hadjihannas MV; Behrens J
    FEBS J; 2014 Feb; 281(3):787-801. PubMed ID: 24251807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer metastasis suppressor 1 modulates SIRT1-dependent p53 deacetylation through interacting with DBC1.
    Liu X; Ehmed E; Li B; Dou J; Qiao X; Jiang W; Yang X; Qiao S; Wu Y
    Am J Cancer Res; 2016; 6(6):1441-9. PubMed ID: 27429856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXKs promote Wnt/β-catenin signaling by translocating DVL into the nucleus.
    Wang W; Li X; Lee M; Jun S; Aziz KE; Feng L; Tran MK; Li N; McCrea PD; Park JI; Chen J
    Dev Cell; 2015 Mar; 32(6):707-18. PubMed ID: 25805136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JRK is a positive regulator of β-catenin transcriptional activity commonly overexpressed in colon, breast and ovarian cancer.
    Pangon L; Ng I; Giry-Laterriere M; Currey N; Morgan A; Benthani F; Tran PN; Al-Sohaily S; Segelov E; Parker BL; Cowley MJ; Wright DC; St Heaps L; Carey L; Rooman I; Kohonen-Corish MR
    Oncogene; 2016 Jun; 35(22):2834-41. PubMed ID: 26455321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer.
    Caca K; Kolligs FT; Ji X; Hayes M; Qian J; Yahanda A; Rimm DL; Costa J; Fearon ER
    Cell Growth Differ; 1999 Jun; 10(6):369-76. PubMed ID: 10392898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.